Home › Prostate Cancer › Connecticut › New Haven
Prostate Cancer clinical trials in New Haven, CT
22 studies for Prostate Cancer are looking for participants at sites in and around New Haven (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
RecruitingPhase 2
- Smilow Cancer Hospital - Yale New Haven Health, New Haven
- Yale-New Haven Hospital-Yale Cancer Center, New Haven
- Smilow Cancer Hospital Phase 1 Unit, New Haven
- and 1 more
A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer
RecruitingPhase 1/2
- Yale Cancer Center, New Haven
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven · 3 mi away
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
RecruitingPhase 1/2
- Yale University, New Haven
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
RecruitingPhase 1
- Yale Cancer Center, New Haven
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
RecruitingPhase 3
- Yale-New Haven Hospital-Yale Cancer Center ( Site 0050), New Haven
- Veterans Affairs Connecticut Healthcare System ( Site 0062), West Haven · 3 mi away
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
RecruitingPhase 1
- Yale New Haven Hospital, New Haven
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RecruitingPhase 2
- Yale Cancer Center, New Haven
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
RecruitingPhase 3
- Yale-New Haven Hospital-Yale Cancer Center ( Site 0064), New Haven
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
RecruitingPhase 3
- Yale University, New Haven
- Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven · 3 mi away
- Smilow Cancer Hospital Care Center - Guilford, Guilford · 13 mi away
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RecruitingPhase 1/2
- Yale University School of Medicine, New Haven
A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
RecruitingPhase 1/2
- GSK Investigational Site, New Haven
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RecruitingPhase 1/2
- Yale Cancer Center, New Haven
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
RecruitingPhase 2
- VA Connecticut Healthcare System West Haven Campus, West Haven, CT, West Haven · 3 mi away
The SUGAR Study; SBRT and Relugolix) for Prostate Cancer
RecruitingPhase 2
- Yale Cancer Center, New Haven
A Single-arm, Multicenter Prospective Study to Evaluate the Diagnostic Performance of PROSTest in Men With PSA ≥ 3ng/ml Using Biopsy as the Sole Ground Truth
RecruitingObservational study
- Wren Laboratories, Branford · 6 mi away
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
RecruitingPhase 2
- New Haven Hospital - Yale Cancer Center, New Haven
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
RecruitingPhase 3
- Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven · 3 mi away
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
RecruitingPhase 1/2
- Yale University (Data Collection Only), New Haven
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
RecruitingObservational study
- Yale University, New Haven
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
RecruitingPhase 1/2
- Yale University, Yale Cancer Center, New Haven
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
RecruitingPhase 2
- Smilow Cancer Center/Yale-New Haven Hospital, New Haven
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · 7 mi away
- and 2 more
About Prostate Cancer
Prostate cancer is one of the most common types of cancer among American men. The risk goes up as men age. Learn about symptoms, tests, and treatment.
More about Prostate Cancer on MedlinePlus
Prostate Cancer trials in other cities
- New York City, NY101 studies
- Houston, TX73 studies
- Los Angeles, CA64 studies
- Boston, MA56 studies
- Seattle, WA45 studies
- St. Louis, MO45 studies
- Chicago, IL45 studies
- Baltimore, MD45 studies
- San Francisco, CA44 studies
- Philadelphia, PA41 studies
- Nashville, TN40 studies
- Washington, DC39 studies
Other studies in New Haven
- Non-Small Cell Lung Cancer40 studies
- Breast Cancer38 studies
- Cancer (all types)35 studies
- Lung Cancer24 studies
- Colorectal Cancer23 studies
- Head and Neck Squamous Cell Carcinoma22 studies
- Metastatic Cancer22 studies
- Ovarian Cancer20 studies
- Opioid Overdose19 studies
- Acute Myeloid Leukemia18 studies
- Alcohol Use Disorder (AUD)18 studies
- Triple-Negative Breast Cancer16 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.